Systemic Sclerosis: Clinical Trials

6 trials for Systemic Sclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 6

Follow Systemic Sclerosis: new trials by email Literature Review of Systemic Sclerosis trials Research Report on Systemic Sclerosis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis
Upfront autologous HSCT - Systemic Sclerosis, Systemic Scleroses, Diffuse
Phase 4CompletedUMC Utrecht602020-09-172026-03-24
Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients
Acetylsalicylic acid, Placebo oral capsule - Systemic Sclerosis
Phase 4CompletedFederal University of São Paulo702018-08-282021-12-01
Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic Sclerosis
Saccharomyces Boulardii Oral Tablet, Metronidazole - Systemic Sclerosis, Small Intestinal Bacterial Overgrowth
Phase 4CompletedCoordinación de Investigación en Salud, Mexico392015-06-012019-07-30
Bosentan in Systemic Sclerosis
Bosentan - Systemic Sclerosis, Digital Ulcers
Phase 4CompletedActelion182011-03-312026-06-03
A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
tadalafil and ambrisentan upfront combination therapy - Pulmonary Arterial Hypertension, Systemic Sclerosis
Phase 4CompletedJohns Hopkins University252010-01-012017-09-12
Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan
Ambrisentan - Systemic Sclerosis, Shortness of Breath
Phase 4CompletedUniversity of California, Los Angeles122009-03-012020-11-02

Narrower conditions

Scleroderma, Systemic (6)  ·  Connective Tissue Diseases (2)  ·  Hypertension, Pulmonary (2)  ·  Dyspnea (1)  ·  Pulmonary Arterial Hypertension (1)  ·  Scleroderma, Diffuse (1)  ·  digital ulcers (1)

Broader conditions

Skin Diseases (6)  ·  Skin and Connective Tissue Diseases (6)  ·  Connective Tissue Diseases (4)  ·  Cardiovascular Diseases (2)  ·  Hypertension (2)  ·  Lung Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  Vascular Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiration Disorders (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Respiratory (1)

Interventions

ambrisentan (2)  ·  Aspirin (1)  ·  Bosentan (1)  ·  Metronidazole (1)  ·  Tadalafil (1)

Sponsors

Actelion (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Federal University of São Paulo (1)  ·  Johns Hopkins University (1)  ·  UMC Utrecht (1)  ·  University of California, Los Angeles (1)

Countries

Netherlands (2)  ·  United States (2)  ·  Brazil (1)  ·  Italy (1)  ·  Mexico (1)  ·  United Kingdom (1)

Top investigators

Cristiane Kayser, PhD (1)  ·  Dinesh Khanna, MD (1)  ·  Jacob M van Laar, MD PhD (1)  ·  Julia Spierings (1)  ·  Paul Hassoun, MD (1)  ·  Rajeev Saggar, MD (1)

Results publications

PMID 22777623, PMID 26360334, PMID 29251556, PMID 31549334, PMID 33737437

NIH funding

P50HL084946 (1)